gastroparesis glp-1 Gastroparesis: Hidden Dangers Beyond C Unmasking Semaglutide-Induced Gastroparesis: The Dangers

Filed Under: Biologics, Endocrinology

Investigational and emerging gastric inhibitory polypeptide (GIP) receptor-based therapies for the treatment of obesity

Overall, PIONEER 5 provides some evidence that oral semaglutide may be an effective treatment option in patients with moderate renal impairment

A review also suggests that GLP-1 drugs may support male reproductive health in those with obesity by improving testosterone levels, reproductive hormones, and sperm quality while also improving metabolic health

GLP-1 agonists bind to the GLP-1 receptor and stimulate it to produce a physiological response, such as an increase in insulin sensitivity or appetite suppression